Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

SensiVida Medical Technologies Inc.

Facebook Twitter LinkedIn Email Comments
SensiVida Medical Technologies Inc. of Henrietta, N.Y., a developer of digital painless diagnostic technologies and devices, has appointed Sidney Braginsky to its board of directors. Braginsky has been president, CEO and chairman of the board of Atropos Technology LLC since 2009. Atropos is the majority shareholder of Digilab LLC, the former molecular spectroscopy division of Bio-Rad, which was acquired by Atropos in 2001. He also served as president of optical products supplier Olympus America Inc. from 1994 to 1999 and as chairman of the International Standards Organization’s Optics and Electro-Optical Systems. SensiVida is developing new diagnostic tools based on microfluidic, nanoarraying solid-state technologies.

BioPhotonics
May 2012
AmericasAtropos TechnologyBio-RadBiophotonicsBusinessDigilabInternational Standards Organization Optics and Electro-Optics SystemsISOmedical diagnostic technologymedical diagnostic testingmedical testingNew YorkOlympus AmericaRapidScanSensiVida Medical TechnologiesSidney Braginsky

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.